Papilozumib 30caps - Hifas da Terra

Papilozumib 30caps - Hifas da Terra

TAKE CARE OF YOUR INTIMATE AREA AND YOUR PARTNER'S BY ACTIVATING THE IMMUNE SYSTEM AND MAINTAINING THE HEALTH OF MUCOUS MEMBRANES

Papilozumbib is a dietary supplement formulated primarily with Reishi, Cordyceps, lion's mane , minerals (zinc and selenium), vitamins (A, C, D3 and E) and lactobacillus probiotics that contribute to the normal functioning of the immune system and the maintenance of mucous membranes.

Papilozumib also helps normalize the vaginal microbiota. An imbalance in the microbiota is associated with the development of infections.

A strong immune system affects the mucous membranes, which are especially important for intimate health and serve as a route of entry for pathogens, especially HPV, genital herpes, and bacteria.

ACTIVATE YOUR IMMUNE SYSTEM FOR PEACE OF MIND AND PROTECTION

Papilozubib is a natural supplement in capsules that targets the immune system, protective mucous membranes, and microbiota. It includes adaptogenic fungi used in Eastern medicine with prebiotic content (Reishi, Lion's Mane, and Cordyceps). Among these, Reishi stands out, a fungus similar to Coriolus versicolor , traditionally used as an adaptogen and stimulator of the body's natural defenses*. FORMULATION CREATED BY EXPERTS IN PURE FUNGI. It also contains probiotics (lactobacillus), vitamins A and C*, and minerals such as selenium and zinc for total protection that helps create a protective barrier in the intimate area and naturally eradicate viruses and bacteria.

VIRUSES AND BACTERIA

IMMUNE SYSTEM AND MUCOUS MEMBRANES

Papilozumib is a natural supplement in capsules with the power of pure mushroom extracts most commonly used in traditional medicine, in perfect synergy with vitamins and minerals with proven efficacy. Papilozumib:

• *contributes to the normal functioning of the immune system and mucous membranes

• It is suitable for patients with HPV without lesions or for men whose partner is HPV positive.

CLINICAL RESULTS WITH PAPILOZUMIB

• 57.9% of female volunteers in the study tested negative for the virus after 3 months of treatment .

Papilozumib is indicated for patients with HPV without lesions to accelerate the virus elimination process, or for men whose partners are HPV-positive. In the Papilozumib study, the following additional information was also available:

• A significant generalized increase in Lactobacillus gasseri was observed
• There was a significant decrease in pH (increased acidity)